Serum levels of soluble intercellular adhesion molecule-1 (s-ICAM-1) and soluble endothelial leukocyte adhesion molecule-1(s-ELAM-1) in amyotrophic lateral sclerosis

References

• Eisen A. Amyotrophic lateral sclerosis is a multifactorial disease. Muscle and Nerve. 1995;18:741–52.
   PubMed Web of Science ®Google Scholar
• McGeer EG, McGeer PL. Neurodegeneration and the immune system. In: Calne DB, editor. Neurodegenerative diseases. Philadelphia: Saunders; 1994. pp. 277–99.
   Google Scholar
• Smith RG, Enghelhardt JT, Tajti J, Appel SH. Experimental immune-mediated motor neuron disease: models for human ALS. Brain Res Bull. 1993;30:373–80.
   PubMed Web of Science ®Google Scholar
• Appel SH, Stockton-Appel V, Stewart SS, Kerman RH. Amyotrophic lateral sclerosis: associated clinical disorders and immunological evaluations. Arch Neurol. 1986;43:224–38.
   Google Scholar
• Pestronk A, Adams RN, Clauson L, Cornblath D, Kunke RM, Griffin D, et al. Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology. 1988;38:1457–61.
   PubMed Web of Science ®Google Scholar
• Younger DS, Rowland LP, Latov N, Sherman W, Pesce M, Lange DJ, et al. Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinaemia and clinical syndromes. Neurology. 1990;40:595–9.
   PubMed Web of Science ®Google Scholar
• Latov N, Hays AP, Donofrio PD, Liao J, Ito H, McGinnis S, et al. Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron diseases. Neurology. 1988;38:763–8.
   PubMed Web of Science ®Google Scholar
• Fratantoni SA, Weisz G, Pardal AM, Reisin RC, Uchitel OD. Amyotrophic lateralsclerosis IgG-treated neuromuscular junctions develop sensitivity to L-type calcium channel blocker. Muscle Nerve. 2000;23:543–50.
   PubMed Web of Science ®Google Scholar
• Benadar M. Antibodies from ALS patients inhibit dopamine release mediated by L-type calcium channels. Neurology. 1999;52:1520–1.
   PubMed Web of Science ®Google Scholar
• Apostolski S, Nikolic J, Bugarski-Prokopljevic C, Miletic V, Pavlovic S, Filipovic S. Serum and CSF immunological findings in ALS. Acta Neurol Scand. 1991;83:96–8.
   PubMed Web of Science ®Google Scholar
• Hartung HP, Archelos JJ, Zielasek J, Gold R, Koltzenburg M, Reiners KH, et al. Circulating adhesion molecules and inflammatory mediators in demyelination: a review. Neurology. 1995; 45(Suppl 6):S22–32.
   Google Scholar
• Ikeda J, Kohriyama T, Nakamura S. Elevation of serum soluble L-selectin and sulfoglucuronyl paragloboside anti- bodies in amyotrophic lateral sclerosis. European Journal of Neurology. 2000;7:541–7.
   PubMedGoogle Scholar
• Ariga T, Kohriyama T, Freddo L, Latov N, Saito M, Kon K, et al. Characterization of sulfated glucuronic acid containing glycolipids reacting with IgM M proteins in patients with neuropathy. J Biol Chem. 1987;262:848–53.
   PubMed Web of Science ®Google Scholar
• Rowland LP, Sherman WL, Hays AP, Lange DJ, Latov N, Trojaborg W, et al. Autopsy-proven amyotrophic lateral sclerosis, Waldenstrom’s macroglobulinaemia, and antibodies to sulfated glucuronic acid paragloboside. Neurology. 1995;45:827–9.
   PubMed Web of Science ®Google Scholar
• Miyatani N, Kohriyama T, Maeda Y, Yu RK. Sulfated glucuronyl paragloboside in rat brain microvessels. J Neurochem. 1990;55:577–82.
   Google Scholar
• Kanda T, Yamawaki M, Ariga T, Yu RK. Interleukin 1 beta up-regulates the expression of sulfoglucuronosyl paraglobo- side, a ligand for L-selectin, in brain microvascular endothe- lial cells. Proc Natl Acad Sci. USA. 1995;92:7897–901.
   Google Scholar
• Brooks BR. El Escorial World Federation of Neurology, criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on motor neuron disease/amyotrophic lateral sclerosis of the World Federation of Neurology Research Group on Neuromuscular Disease and the El Escorial ‘Clinical limits of amyotrophic lateral sclerosis’ workshop contributors. J Neurol Sci. 1994;124:96–107.
   Google Scholar
• Trojano M, Avolio C, Ruggieri M, De Robertis F, Giuliani F, Paolicelli D, et al. Soluble intercellular adhesion molecule-1 (sICAM-1) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system. Multiple Sclerosis. 1998;4:39–44.
   Google Scholar
• Musso AM, Zanusso GL, Bonazzi ML, Tomelleri G, Bonetti B, Moretto G, et al. Increased serum levels of ICAM-1, ELAM-1 and TNF-alpha inflammatory disorders of the peripheral nervous system. Ital J Neurol Sci. 1994;15:267–71.
   PubMedGoogle Scholar
• Nobuyuki O, Akiguchi I, Kawasaki T, Ohnishi K, Kimura J. Elevated serum levels of endothelial leukocyte adhesion molecules in Guillain-Barre syndrome and chronic inflam- matory demyelinating polyneuropathy. Ann Neurol. 1994;35:621–4.
   Google Scholar
• Dore-Duffy P, Neuman W, Balabanov R, Lisak DP, Mainolfi E, Rothlein R, et al. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity. Ann Neurol. 1995;37:55–62.
   PubMedGoogle Scholar
• Oka N, Akigushi I, Nagao M, Nishio T, Kawasaki T, Kimura J. Expression of endothelial leukocyte molecule-1 (ELAM) in chronic inflammatory demyelinating polyneuro- pathy. Neurol. 1994;44:946–50.
   Google Scholar
• Verbeek MM, Otte-Holler I, Westphal JR, Wesseling P, Ruiter DJ, MW deWaal R. Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer’s disease. Am J Pathol. 1994;144:104–16.
   Google Scholar